Strategic Consulting

White Paper

Why Do So Many Phase III Fail?

December 12, 2022
Webinar

Assessing Treatment Efficacy in Early-Phase Oncology Trials

February 3, 2022
Webinar

Assessing Activity in Early-Phase Trials in Oncology: Current Designs for Expansion Cohorts and Phase II

December 2, 2021
Webinar

Phase I Trials in Oncology: Pros and Cons of Current Designs

October 21, 2021
Article

Immunotherapy Against Cancer: Challenge and Opportunities

August 4, 2021
Webinar

Clinical Trials for, and Despite, COVID-19

October 27, 2020
Webinar

Companion Diagnostics and Clinical Development in Oncology: a Statistical Perspective

September 17, 2020
Article

Evaluating the Potential of Relapse-Free Survival as a Surrogate for Overall Survival in the Adjuvant Therapy of Melanoma with Checkpoint Inhibitors

August 10, 2020
Webinar

Clinical Endpoints and Treatment Effect in Immuno-Oncology

June 15, 2020
Article

Assessing Treatment Benefit in Immuno-oncology

June 9, 2020

When every data point represents a patient, accuracy and integrity aren’t optional — they’re everything. That’s why it’s IDDI.

Start Now